Cited by 391Nanoparticle-Based Drug DeliveryVirus-based gene therapy researchBacteriophages and microbial interactions

Viral Nanoparticles for Drug Delivery, Imaging, Immunotherapy, and Theranostic Applications

Open access
Chung, Young Hun, Cai, Hui, Steinmetz, Nicole F.·2020·Advanced Drug Delivery Reviews

Abstract

Viral nanoparticles (VNPs) encompass a diverse array of naturally occurring nanomaterials derived from plant viruses, bacteriophages, and mammalian viruses. The application and development of VNPs and their genome-free versions, the virus-like particles (VLPs), for nanomedicine is a rapidly growing. VLPs can encapsulate a wide range of active ingredients as well as be genetically or chemically conjugated to targeting ligands to achieve tissue specificity. VLPs are manufactured through scalable fermentation or molecular farming, and the materials are biocompatible and biodegradable. These properties have led to a wide range of applications, including cancer therapies, immunotherapies, vaccines, antimicrobial therapies, cardiovascular therapies, gene therapies, as well as imaging and theranostics. The use of VLPs as drug delivery agents is evolving, and sufficient research must continuously be undertaken to translate these therapies to the clinic. This review highlights some of the novel research efforts currently underway in the VNP drug delivery field in achieving this greater goal.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2020.06.024

Cites

232 of 232 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • VLPs can be used as carriers to deliver small molecules, genes and nucleic acids, or peptides and proteins in cancer therapies, immunotherapies, vaccines and gene therapies.

    “VLPs can be used as carriers to deliver small molecules, genes and nucleic acids, or peptides and proteins in cancer therapies, immunotherapies, vaccines and gene therapies [81].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [145]Sinovac Biotech to Move Ahead with COVID-19 Vaccine Trial in China https://www.pharmaceutical-business-review.com/news/sinovac-biotech-covid-19-vaccine-trial/ 2020 accessed April 20, 2020

Cited by

Sorted by citations

Authors
Chung, Y. H., Cai, H., & Steinmetz, N. F.
Affiliations
University of California San Diego (US)
Corresponding author
Steinmetz, Nicole F.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2020
Volume
156
Pages
214-235
ISSN
0169-409X (ISSN-L)
OpenAlex
W3037462895
Cited by
391
References
232
Citations by year
2026: 29 · 2025: 52 · 2024: 83 · 2023: 71 · 2022: 88 · 2021: 61 · 2020: 7
FWCI
3.80
Type
journal article
Language
en
Open access
Locations
  • Advanced Drug Delivery Reviews (acceptedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • American Cancer Society
  • Foundation for the National Institutes of Health
  • National Science Foundation
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Physical Sciences › Environmental Science › Ecology › Bacteriophages and microbial interactions
Keywords
viral nanoparticles, virus-like particles, drug delivery, theranostics, immunotherapy, molecular farming, plant viruses, bacteriophages, cancer therapy, vaccines, gene therapy, antimicrobial therapy, cardiovascular disease treatment, imaging, targeting ligands, biodegradable nanomaterials
MeSH terms
Theranostic Nanomedicine, Animals, Diagnostic Imaging, Humans, Immunotherapy, Vaccines, Viruses, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review